Value of serum glucagon like peptide-1 detection in assessment of Alzheimer's disease

Value of serum glucagon like peptide-1 detection in assessment of Alzheimer's disease

Objective: To study the value of serum glucagon like peptide-1 detection in assessment of Alzheimer’s disease. Methods: A total of 35 cases of patients with Alzheimer’s disease were enrolled in AD group, 35 cases of patients with type 2 diabetes mellitus were enrolled in T2DM group, 35 cases of A...

Full description

Bibliographic Details
Main Authors:	Dong-Ming Wang, Lin-Lin Liu
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-02-01
Series:	Journal of Hainan Medical University
Subjects:	Alzheimer’s disease Glucagon like peptide-1 Tau protein β-amyloid protein Inflammation Oxidative stress
Online Access:	http://www.jhmuweb.net/PDF/201604/24.pdf

Similar Items

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

The potential value of capsaicin in modulating cognitive functions in a rat model of streptozotocin-induced Alzheimer’s disease
by: Manal A. Shalaby, et al.
Published: (2019-07-01)

Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
by: Hua Zhang, et al.
Published: (2018-09-01)

Pathophysiology of Alzheimer’s Disease
by: Mohammad Amani
Published: (2017-01-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-03-01)

Alzheimer’s Disease—A Panorama Glimpse
by: Li Na Zhao, et al.
Published: (2014-07-01)

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
by: Susana López-Ortiz, et al.
Published: (2021-03-01)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
by: Joana R. Guedes, et al.
Published: (2018-08-01)

β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
by: Xiaojuan eSun, et al.
Published: (2015-09-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
by: Roberta Cascella, et al.
Published: (2021-05-01)

An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease
by: Qing Xie, et al.
Published: (2019-07-01)

Peptide Interference with APP and Tau Association: Relevance to Alzheimer’s Disease Amelioration
by: Ruth Maron, et al.
Published: (2020-05-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
by: Sylvain Lehmann, et al.
Published: (2020-10-01)

The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression
by: Yunjun Ge, et al.
Published: (2014-11-01)

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
by: Yun Kyung Jeon, et al.
Published: (2014-12-01)

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
by: Zeinab Breijyeh, et al.
Published: (2020-12-01)

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
by: V.L. Orlenko, et al.
Published: (2014-05-01)

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
by: Won-Young Lee
Published: (2017-02-01)

Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer
by: Trivedi, Shivangi
Published: (2011)

Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer
by: Trivedi, Shivangi
Published: (2011)

Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
by: Hun Jee Choe, et al.
Published: (2021-02-01)

Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
by: C. Guo, et al.

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon‐like peptide‐1 on glomeruli and tubules in diabetic rats
by: Weiqin Yin, et al.
Published: (2019-05-01)

Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations
by: Charuvaka Muvva, et al.
Published: (2021-03-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)

The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
by: Choon Sang Bae, et al.
Published: (2017-11-01)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

The maze of APP processing in Alzheimer’s disease: Where did we go wrong in reasoning?
by: Ming eChen
Published: (2015-05-01)

The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
by: Baocheng Xie, et al.
Published: (2021-06-01)

Assessing the Possible Influence of Residues of Ractopamine, a Livestock Feed Additive, in Meat on Alzheimer Disease
by: Frank S. Fan
Published: (2021-05-01)

Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
by: Kevin A. Clayton, et al.
Published: (2017-12-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease
by: Jiyoung Kim
Published: (2021-03-01)

Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissue
by: Claire E. Shepherd, et al.
Published: (2020-07-01)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
by: Jonas Ronn, et al.
Published: (2017-12-01)